210 related articles for article (PubMed ID: 12084454)
1. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression.
Mercatante DR; Kole R
Biochim Biophys Acta; 2002 Jul; 1587(2-3):126-32. PubMed ID: 12084454
[TBL] [Abstract][Full Text] [Related]
2. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.
Mercatante DR; Sazani P; Kole R
Curr Cancer Drug Targets; 2001 Nov; 1(3):211-30. PubMed ID: 12188880
[TBL] [Abstract][Full Text] [Related]
3. RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes.
Wilton SD; Fletcher S
Curr Gene Ther; 2011 Aug; 11(4):259-75. PubMed ID: 21453280
[TBL] [Abstract][Full Text] [Related]
4. Comparison of basic peptides- and lipid-based strategies for the delivery of splice correcting oligonucleotides.
Thierry AR; Abes S; Resina S; Travo A; Richard JP; Prevot P; Lebleu B
Biochim Biophys Acta; 2006 Mar; 1758(3):364-74. PubMed ID: 16360115
[TBL] [Abstract][Full Text] [Related]
5. Modification of alternative splicing pathways as a potential approach to chemotherapy.
Mercatante D; Kole R
Pharmacol Ther; 2000 Mar; 85(3):237-43. PubMed ID: 10739878
[TBL] [Abstract][Full Text] [Related]
6. Modification of pre-mRNA splicing by antisense oligonucleotides.
Kole R
Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712
[TBL] [Abstract][Full Text] [Related]
7. Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.
Aung-Htut MT; McIntosh CS; Ham KA; Pitout IL; Flynn LL; Greer K; Fletcher S; Wilton SD
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614438
[TBL] [Abstract][Full Text] [Related]
8. Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.
Karras JG; McKay RA; Dean NM; Monia BP
Mol Pharmacol; 2000 Aug; 58(2):380-7. PubMed ID: 10908306
[TBL] [Abstract][Full Text] [Related]
9. Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.
Mourich DV; Iversen PL
Curr Opin Mol Ther; 2009 Apr; 11(2):124-32. PubMed ID: 19330718
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers.
Sahin I; George A; Seyhan AA
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769221
[TBL] [Abstract][Full Text] [Related]
11. Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides.
Sierakowska H; Sambade MJ; Agrawal S; Kole R
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12840-4. PubMed ID: 8917506
[TBL] [Abstract][Full Text] [Related]
12. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
[TBL] [Abstract][Full Text] [Related]
13. Antisense therapeutics: New ways to nudge splicing.
Eperon I
Nat Chem Biol; 2012 May; 8(6):507-8. PubMed ID: 22596201
[No Abstract] [Full Text] [Related]
14. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.
Schmajuk G; Sierakowska H; Kole R
J Biol Chem; 1999 Jul; 274(31):21783-9. PubMed ID: 10419493
[TBL] [Abstract][Full Text] [Related]
15. Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.
Jyotsana N; Heuser M
Expert Opin Ther Targets; 2018 Feb; 22(2):107-121. PubMed ID: 29235382
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides.
Wang Z; Jeon HY; Rigo F; Bennett CF; Krainer AR
Open Biol; 2012 Oct; 2(10):120133. PubMed ID: 23155487
[TBL] [Abstract][Full Text] [Related]
17. Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain.
Karras JG; Maier MA; Lu T; Watt A; Manoharan M
Biochemistry; 2001 Jul; 40(26):7853-9. PubMed ID: 11425312
[TBL] [Abstract][Full Text] [Related]
18. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
Urbanski LM; Leclair N; Anczuków O
Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
[TBL] [Abstract][Full Text] [Related]
19. Progress toward therapy with antisense-mediated splicing modulation.
Du L; Gatti RA
Curr Opin Mol Ther; 2009 Apr; 11(2):116-23. PubMed ID: 19330717
[TBL] [Abstract][Full Text] [Related]
20. RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes.
Wilton SD; Fletcher S
Curr Gene Ther; 2005 Oct; 5(5):467-83. PubMed ID: 16250888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
